Compare Illumina, Inc. (ILMN) vs Monster Beverage Corp (MNST) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Illumina, Inc. vs Monster Beverage Corp — how do they compare? Illumina, Inc. trades at $265 (market cap $39.95B), while Monster Beverage Corp trades at $43.62 (market cap $85.51B). The key difference: Monster Beverage Corp is far larger — about 2.1× Illumina, Inc.'s market cap, and Illumina, Inc. is trading nearer its 52-week high, Monster Beverage Corp nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Illumina, Inc. for 83 Days and Monster Beverage Corp for 72 Days on average.
| ILMN | MNST | |
|---|---|---|
Market Cap | $39.95B | $85.51B |
Volume | 3,169,503 | 8,569,709 |
Sector | Health | Consumer Staples |
52-Week High | $293.69 | $49.97 |
52-Week Low | $91.00 | $33.16 |
Typical Hold Time | 83 Days | 72 Days |
Enterprise Value | $41.31B | $83.81B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Illumina (ILMN) trades at $267.76, down 2.11% on the day but remains near its 52-week high. The stock exhibits a bullish technical trend with strong moving average signals, while recent earnings beats and a significant return to profitability in 2025 highlight fundamental improvement. Positive sentiment is fueled by S&P 500 inclusion and analyst upgrades, though high valuation ratios present a risk.
The outlook is cautiously optimistic, driven by sequencing growth and AI initiatives, but investors face risks from elevated valuations, competitive pressures, and potential margin volatility. The consensus price target of $241 suggests near-term downside from current levels despite a majority of analysts maintaining a Buy rating.
Monster Beverage (MNST) trades at $42.88, down 0.86% on the day, with technical indicators showing bearish momentum despite strong fundamental performance. The company reported robust Q2 2026 earnings, beating estimates with $0.30 EPS, and maintains impressive profitability metrics including 55.55% gross margin and 23.08% net income margin. Recent news highlights Monster's debt-free balance sheet and international expansion driving 35% overseas sales growth.
While valuation multiples appear elevated (P/E 39.7, P/S 9.18), Monster's consistent earnings beats and analyst consensus price target of $98.22 suggest significant upside potential. Key risks include regulatory challenges in international markets and competitive pressures, but the company's strong cash flow generation and market position support long-term growth prospects.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Illumina, Inc.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Read more on ILMN →About Monster Beverage Corp
Monster Beverage is a leader in the energy drink subsegment of the beverage industry. The Monster trademark anchors the portfolio, and notable offerings include Monster Energy and Monster Ultra. The firm has also started to incubate new trademarks for emerging enclaves of the energy space, like Reign in performance energy. It is primarily a brand owner, outsourcing most of its manufacturing processes to third-party copackers. It primarily uses the Coca-Cola bottling system for distribution after a strategic agreement in which Coke became Monster's largest shareholder (nearly 20%) and that also included the exchange of certain businesses between the two firms. Most of Monster's revenue is generated in the United States, though international geographies are increasing in the mix.
Read more on MNST →
